Limit Bleeding Risk in Patients Who Need an Anticoagulant Plus Antiplatelets

April 2017

Debate continues about how to manage patients on an anticoagulant (warfarin, etc) who also need antiplatelets (aspirin, etc).

Many patients end up on "triple antithrombotic therapy"...such as warfarin for atrial fib PLUS clopidogrel and aspirin after a stent.

But bleeding risk is high. One in 50 patients will have a serious bleed in the first month of triple therapy...and 1 in 8 in the first year.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote